Hegen Li

861 total citations
44 papers, 653 citations indexed

About

Hegen Li is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Hegen Li has authored 44 papers receiving a total of 653 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pulmonary and Respiratory Medicine, 15 papers in Oncology and 14 papers in Molecular Biology. Recurrent topics in Hegen Li's work include Lung Cancer Treatments and Mutations (14 papers), Lung Cancer Diagnosis and Treatment (9 papers) and Lung Cancer Research Studies (6 papers). Hegen Li is often cited by papers focused on Lung Cancer Treatments and Mutations (14 papers), Lung Cancer Diagnosis and Treatment (9 papers) and Lung Cancer Research Studies (6 papers). Hegen Li collaborates with scholars based in China, Norway and United States. Hegen Li's co-authors include Jianhui Tian, Yi Jiang, Jiaxiang Liu, Wei Huang, Deyue Yan, Zhu-Jun Mao, Lingshuang Liu, Hua Jin, Mingliang Liu and Mo Sun and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biomaterials and Scientific Reports.

In The Last Decade

Hegen Li

38 papers receiving 637 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hegen Li China 14 256 190 159 132 109 44 653
Vanminh Le China 14 226 0.9× 116 0.6× 108 0.7× 159 1.2× 93 0.9× 17 583
Qinxin Zhao China 6 238 0.9× 113 0.6× 137 0.9× 201 1.5× 102 0.9× 16 647
Yaodong Chen China 16 356 1.4× 113 0.6× 98 0.6× 184 1.4× 131 1.2× 35 715
Hongzhuan Yin China 19 539 2.1× 115 0.6× 164 1.0× 144 1.1× 253 2.3× 35 915
Qiang Tong China 19 554 2.2× 182 1.0× 145 0.9× 69 0.5× 219 2.0× 63 917
Xu He China 19 358 1.4× 213 1.1× 143 0.9× 197 1.5× 281 2.6× 49 912
Dong‐Sheng Huang China 13 317 1.2× 139 0.7× 47 0.3× 120 0.9× 140 1.3× 31 671
Lifeng Wang China 15 334 1.3× 230 1.2× 186 1.2× 136 1.0× 166 1.5× 44 754
Liqin Yuan China 15 279 1.1× 175 0.9× 74 0.5× 94 0.7× 162 1.5× 29 676

Countries citing papers authored by Hegen Li

Since Specialization
Citations

This map shows the geographic impact of Hegen Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hegen Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hegen Li more than expected).

Fields of papers citing papers by Hegen Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hegen Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hegen Li. The network helps show where Hegen Li may publish in the future.

Co-authorship network of co-authors of Hegen Li

This figure shows the co-authorship network connecting the top 25 collaborators of Hegen Li. A scholar is included among the top collaborators of Hegen Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hegen Li. Hegen Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Yao, Yiming Lu, Zhiyi Zhou, et al.. (2025). Targeted deprivation of STAT6 sensitizes acute lymphoblastic leukemia cells to cytarabine in vivo and in vitro: clinical implications. Cell Death and Disease. 16(1). 669–669.
2.
Bai, Haoran, Xinyu Zhu, Lu Gao, et al.. (2025). ERG mediates the differentiation of hepatic progenitor cells towards immunosuppressive PDGFRα+ cancer-associated fibroblasts during hepatocarcinogenesis. Cell Death and Disease. 16(1). 26–26. 2 indexed citations
3.
Zhang, Yu, et al.. (2025). Synergistic Gambogic acid nanomedicine and mild photothermal therapy suppress metastatic lung cancer. Materials & Design. 256. 114320–114320.
4.
Zhang, Yu, Hegen Li, Xuliang Li, et al.. (2024). Camptothecin-loaded and IR780-doped polydopamine nanomedicine used for multifunctional chemo-photothermal-photodynamic therapy for lung cancer. Journal of Drug Delivery Science and Technology. 97. 105657–105657. 7 indexed citations
5.
Zhu, Lihua, et al.. (2024). Cycloastragenol induces apoptosis and protective autophagy through AMPK/ULK1/mTOR axis in human non-small cell lung cancer cell lines. Journal of Integrative Medicine. 22(4). 503–514. 11 indexed citations
6.
7.
Chen, Yukun, et al.. (2024). Investigating the immune mechanism of natural products in the treatment of lung cancer. Frontiers in Pharmacology. 15. 1289957–1289957. 3 indexed citations
8.
Yang, Yun, Li Zhu, Yu Pan, et al.. (2023). Jinfukang inhibits clustering and invasion of circulating lung tumor cells by regulating the EGFR signaling pathway. Acta Biochimica et Biophysica Sinica. 55(11). 1851–1854. 1 indexed citations
9.
10.
Luo, Bin, Zujun Que, Dan Qi, et al.. (2023). Identification of exosome protein panels as predictive biomarkers for non-small cell lung cancer. Biological Procedures Online. 25(1). 29–29. 16 indexed citations
11.
Niu, Qun, Yanyan Lin, Changsheng Dong, et al.. (2022). Antileukemic effects of topoisomerase I inhibitors mediated by de-SUMOylase SENP1. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1868(12). 166492–166492. 9 indexed citations
12.
Que, Zujun, Zhiyi Zhou, Yu Pan, et al.. (2021). Jinfukang inhibits lung cancer metastasis by upregulating CX3CL1 to recruit NK cells to kill CTCs. Journal of Ethnopharmacology. 275. 114175–114175. 22 indexed citations
13.
Que, Zujun, Bin Luo, Yi Jiang, et al.. (2020). Proteomics analysis of tumor exosomes reveals vital pathways of Jinfukang inhibiting circulating tumor cells metastasis in lung cancer. Journal of Ethnopharmacology. 256. 112802–112802. 12 indexed citations
14.
Que, Zujun, Zhiyi Zhou, Bin Luo, et al.. (2019). Jingfukang induces anti-cancer activity through oxidative stress-mediated DNA damage in circulating human lung cancer cells. BMC Complementary and Alternative Medicine. 19(1). 204–204. 23 indexed citations
15.
Zhang, Zhanxia, Changsheng Dong, Guanzhen Yu, et al.. (2019). Smart and dual-targeted BSA nanomedicine with controllable release by high autolysosome levels. Colloids and Surfaces B Biointerfaces. 182. 110325–110325. 10 indexed citations
16.
Jiao, Lijing, Changsheng Dong, Jiaxiang Liu, et al.. (2017). Effects of Chinese Medicine as Adjunct Medication for Adjuvant Chemotherapy Treatments of Non-Small Cell Lung Cancer Patients. Scientific Reports. 7(1). 46524–46524. 55 indexed citations
17.
18.
Xu, Ling, Hegen Li, Lingshuang Liu, et al.. (2012). Multi-center randomized double-blind controlled clinical study of chemotherapy combined with or without traditional Chinese medicine on quality of life of postoperative non-small cell lung cancer patients. BMC Complementary and Alternative Medicine. 12(1). 112–112. 34 indexed citations
19.
Li, Hegen. (2011). Survival Analysis of Elderly Patients with Advanced Non-small CellLung Cancer Received Traditional Chinese Medicine Intervention. 1 indexed citations
20.
Li, Hegen. (2009). Supplementing Qi and Nourishing Yin Prescription Combined with Chemotherapy for 30 Cases with Non-small Cell Lung Cancer. Journal of Oncology. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vanminh Le Breakdown of academic impact, for papers by Qinxin Zhao Breakdown of academic impact, for papers by Yaodong Chen Breakdown of academic impact, for papers by Hongzhuan Yin Breakdown of academic impact, for papers by Qiang Tong Breakdown of academic impact, for papers by Xu He Breakdown of academic impact, for papers by Dong‐Sheng Huang Breakdown of academic impact, for papers by Lifeng Wang Breakdown of academic impact, for papers by Liqin Yuan
Rankless by CCL
2026